SecBot SecBot
Insider Cluster (3 insiders) ·Filed Sep 2, 2026

RXST

RxSight, Inc.
NEUTRAL
Impact 3/10
Horizonimmediate Processed1mo ago
Insider cluster: 3 insiders, $0.1M total
Actionable Insight • Neutral

The cluster of C-suite option exercises followed by same-day sales at a uniform price is consistent with routine tax-motivated selling after vesting, not a bearish signal. With no earnings, offering, or late-filing context to amplify the cluster, this is a non-event for the stock. Monitor next quarterly filing for any deterioration in fundamentals, which have been driving the stock's recent decline.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
RXST ▼ -28.44% at T+20d
NEUTRAL call -28.44% · α vs SPY -27.25% · entry $6.54 → $4.68
Next anchor: T+60d in 4w
Latest observation: T+35 -30.61% FF3 residual α
Entry = T+0 close
Sep 2, 2026
via day close
T+1d
-2.52%
call -2.52% · α -2.14%
$6.38
settled 8w ago
T+5d
-7.95%
call -7.95% · α -6.80%
$6.02
settled 7w ago
T+20d
-28.44%
call -28.44% · α -27.25%
$4.68
settled 26d ago
T+60d
Pending
in 4w

Price Chart

Loading chart...

Executive Summary

Three C-suite insiders at RxSight (CFO, CMO, COO) sold a total of $104K in open-market sales on September 2, 2026, following the exercise of stock options on August 31. The sales are small relative to the $292M market cap (0.04%), but the cluster of C-suite selling at the same price ($6.96) after option exercises suggests a coordinated window for liquidity rather than a bearish signal. The sales are routine in size and pattern, warranting a neutral read.

Key Financial Metrics

Direction
selling
Total Value
$104.0K
Insiders
3

Key Facts

  • CFO Mark Wilterding sold 7,765 shares for $54K on Sept 2
  • CMO Ronald Kurtz sold 5,100 shares for $35K on Sept 2
  • COO Ilya Goldshleger sold 2,041 shares for $14K on Sept 2
  • All three insiders exercised stock options at $0 on Aug 31 before selling
  • Total open-market sales of $104K represent 0.04% of $292M market cap
  • All sales executed at the same price of $6.96 per share

Financial Impact

Total insider sales of $104K, representing 0.04% of market cap — immaterial

insider ownership

Risk Factors

  • Continued selling pressure from insiders if the stock rallies
  • Potential negative catalyst from upcoming earnings if fundamentals continue to weaken

Market Snapshot

Exchange
Nasdaq
Sector
Ophthalmic Goods
Analyst Consensus
7% bullish (15 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RXST-1788400869366
5 reports for RXST
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for RXST — sortable, filterable
TypeNow
Oct 20, 2026
6d ago
Press Release
NEUTRAL ★ 2/10
$4.90awaiting T+20—$4.92 (+0.41%)
Sep 2, 2026
7w ago
Insider Cluster
BEARISH ★ 4/10
$6.54 $4.68▲ +28.44%▲ +27.25%$4.92 (+24.77%)
Sep 2, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$6.54 $4.68▼ −28.44%▼ −27.25%$4.92 (−24.77%)
Apr 22, 2026
26w ago
Press Release
NEUTRAL ★ 1/10
$7.20 $6.16▼ −14.44%▼ −19.08%$4.92 (−31.67%)
Feb 27, 2026
34w ago
EFFECT
NEUTRAL ★ 4/10
$7.48 $6.26▼ −16.31%▼ −8.75%$4.92 (−34.22%)
Showing 5 of 5

US Market Status

Market Open — Closes in 5h 21m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 2, 2026